Abstract
Tumor targeted therapy has brought a new hope to the cancer patients. With the recent advances in nanotechnology and growing knowledge on unique cancer biomarkers, it is now possible to manipulate the surface architecture of polymeric nanoscale delivery systems with targeting moieties, such as antibodies, antibody fragments, specific molecules, small peptides, RNA aptamers etc. to target specific receptors and antigens present exclusively or overexpressed on the tumor cell surface or on the tumor endothelial cell surface. These modified polymeric nanoparticles deliver the loaded chemotherapeutics preferentially to the tumor tissue and not to the healthy tissue. This ensures highly targeted treatment without severe side effects which are normally experienced by the cancer patients in case of conventional chemotherapy. Such specifically constructed polymeric nanocarriers with improved tumor targeting profile are now regarded as engineered polymeric nanoparticles, which have become one of the prime areas of drug delivery research in recent times. This review describes specific approaches used in recent years to construct engineered polymeric nanoparticles, their emerging potential for cancer therapy and recent advances in tumor targeting. An equal attention has been devoted to the fundamental problems encountered in practical fields which limit their clinical use and industrial production.
Keywords: Active targeting, challenges, monoclonal antibody, polymeric nanoparticles, receptor, tumor targeting.
Current Pharmaceutical Biotechnology
Title:Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles
Volume: 14 Issue: 15
Author(s): Biswajit Mukherjee, Bhabani S. Satapathy, Laboni Mondal, Niladri S. Dey and Ruma Maji
Affiliation:
Keywords: Active targeting, challenges, monoclonal antibody, polymeric nanoparticles, receptor, tumor targeting.
Abstract: Tumor targeted therapy has brought a new hope to the cancer patients. With the recent advances in nanotechnology and growing knowledge on unique cancer biomarkers, it is now possible to manipulate the surface architecture of polymeric nanoscale delivery systems with targeting moieties, such as antibodies, antibody fragments, specific molecules, small peptides, RNA aptamers etc. to target specific receptors and antigens present exclusively or overexpressed on the tumor cell surface or on the tumor endothelial cell surface. These modified polymeric nanoparticles deliver the loaded chemotherapeutics preferentially to the tumor tissue and not to the healthy tissue. This ensures highly targeted treatment without severe side effects which are normally experienced by the cancer patients in case of conventional chemotherapy. Such specifically constructed polymeric nanocarriers with improved tumor targeting profile are now regarded as engineered polymeric nanoparticles, which have become one of the prime areas of drug delivery research in recent times. This review describes specific approaches used in recent years to construct engineered polymeric nanoparticles, their emerging potential for cancer therapy and recent advances in tumor targeting. An equal attention has been devoted to the fundamental problems encountered in practical fields which limit their clinical use and industrial production.
Export Options
About this article
Cite this article as:
Mukherjee Biswajit, Satapathy S. Bhabani, Mondal Laboni, Dey S. Niladri and Maji Ruma, Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles, Current Pharmaceutical Biotechnology 2013; 14 (15) . https://dx.doi.org/10.2174/1389201015666140608143235
DOI https://dx.doi.org/10.2174/1389201015666140608143235 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
Current Topics in Medicinal Chemistry Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Editorial [Hot Topic: Hydrogen Sulfide: From Molecular Biology to Pharmacology Guest Editor: Stefano Fiorucci)]
Inflammation & Allergy - Drug Targets (Discontinued) Drug Encapsulated Nanoparticles for Treating Targeted Cells
Current Medicinal Chemistry 177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma
Current Radiopharmaceuticals Gallic Acid Attenuates Oleic Acid-induced Proliferation of Vascular Smooth Muscle Cell Through Regulation of AMPK-eNOS-FAS Signaling
Current Medicinal Chemistry Trace of Long Non-Coding RNAs in Signaling Pathways in Thyroid Cancer
Current Signal Transduction Therapy Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry The Effect of Drugs on the Labeling of Blood Elements with Technetium-99m
Current Pharmaceutical Design Pharmacogenetics, Pharmacogenomics and Epigenetics of Nrf2-regulated Xenobioticmetabolizing Enzymes and Transporters by Dietary Phytochemical and Cancer Chemoprevention
Current Drug Metabolism N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery TRPM8 Biology and Medicinal Chemistry
Current Topics in Medicinal Chemistry An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis
MicroRNA CEACAM1 in Malignant Melanoma: A Diagnostic and Therapeutic Target
Current Topics in Medicinal Chemistry Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine Therapeutic Potential of Targeting PAK Signaling
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Survivin as a Prognostic/Predictive Marker and Molecular Target in Cancer Therapy
Current Medicinal Chemistry Multifunctional Nanoparticles, Nanocages and Degradable Polymers as a Potential Novel Generation of Non-Invasive Molecular and Cellular Imaging Systems
Recent Patents on Nanotechnology Antigene and Antiproliferative Effects of Triplex-Forming Oligonucleotide (TFO) Targeted on hmgb1 Gene in Human Hepatoma Cells
Anti-Cancer Agents in Medicinal Chemistry